Afstyla recombinant and Bupropion Tablets and Sustained-Release Tablets
Determining the interaction of Afstyla recombinant and Bupropion Tablets and Sustained-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla recombinant-Burapren Injection
- Afstyla recombinant-Burn-O-Jel Topical application
- Afstyla recombinant-Burnamycin Topical application
- Afstyla recombinant-Burosumab
- Afstyla recombinant-Burosumab-twza
- Afstyla recombinant-Burosumab-twza Subcutaneous
- Bupropion Tablets and Sustained-Release Tablets-Aftera
- Bupropion Tablets and Sustained-Release Tablets-Aftertest Topical Pain Relief
- Bupropion Tablets and Sustained-Release Tablets-Agalsidase beta
- Bupropion Tablets and Sustained-Release Tablets-Agalsidase beta Intravenous
- Bupropion Tablets and Sustained-Release Tablets-Agenerase
- Bupropion Tablets and Sustained-Release Tablets-Aggrastat